Indices of Therapeutic Outcome in Pharmacoeconomic Evaluation of Drug Therapy

Alberto JA, Washington AE. Cost-effectiveness of prenatal screening and immunization for hepatitis B virus. Journal of the American Medical Association 259: 365–369, 1988

Antczak-Bouckoms AA, Weinstein MC. Cost-effectiveness analysis of periodontal disease control. Journal of Dental Research 66: 1630–1635, 1987

Drummond MF, Stoddart GL. Economic analysis and clinical trials. Controlled Clinical Trials 5: 115–128, 1984

Drummond MF, Stoddart GL, Torrance GW. (1987) Methods for the economic evaluation of health care programmes. Oxford University Press, Oxford, 1987

Freund DA, Dittus RS. Principles of pharmacoeconomic analysis of drug therapy. PharmacoEconomics 1: 20–29, 1992

Gelber RD, Gelman RS, Goldhirsch A. A quality-of-life-oriented endpoint for comparing therapies. Biometrics 45: 781–795, 1989

Goldhirsch A, Gelber RD, Simes RJ, Glasziou P, Coates AS. Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis. Journal of Clinical Oncology 7: 36–44, 1989

Goldman L, Sia STB, Cook E, Rutherford JD, Weinstein MC. Costs and effectiveness of routine therapy with long-term beta-adrenergic antagonists after acute myocardial infarction. New England Journal of Medicine 319: 152–157, 1988

Goldman L, Weinstein MC, Goldman PA, Williams LW. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. Journal of the American Medical Association 265: 1145–1151, 1991

Graham NMH, Zeger SL, Park LP, Phair JP, Detels R, et al. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. Lancet 338: 265–269, 1991

Hay JW, Wittels EH, Gotto Jr AM. An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction. American Journal of Cardiology 67: 789–796, 1991

Hillner BE, Smith TJ. Efficacy and cost-effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. New England Journal of Medicine 324: 160–168, 1991

Hutchison BG, Stoddart GL. Cost-effectiveness of primary tetanus vaccination among elderly Canadians. Canadian Medical Association Journal 139: 1143–1151, 1988

Jaakkimainen L, Goodwin PJ, Pater J, Warde P, Murray N, et al. Counting the cost of chemotherapy in a National Cancer Institute of Canada randomized trial in non small-cell lung cancer. Journal of Clinical Oncology 8: 1301–1309, 1990

Jasper AC, Mohsenifar Z, Kahan S, Goldberg HS, Koerner SK. Cost-benefit comparison of aerosol bronchodilator delivery methods in hospitalized patients. Chest 91: 614–618, 1987

Joesoef MR, Remington PL, Jiptoherijanto PT. Epidemiological model and cost-effectiveness analysis of tuberculosis treatment programmes in Indonesia. International Journal of Epidemiology 18: 174–179, 1989

Kinosian BP, Eisenberg JM. Cutting into cholesterol. Cost-effective alternatives for treating hypercholesterolemia. Journal of the American Medical Association 259: 2249–2254, 1988

Laird NM, Mosteller F. Some statistical methods for combining experimental results. International Journal of Technological Assessment in Health Care 6: 5–30, 1990

Martens LL, Rutten FFH, Erkelens W, Ascoop CAPL. Clinical benefits and cost-effectiveness of lowering serum cholesterol levels: the case of simvastatin and cholestyramine in the Netherlands. American Journal of Cardiology 65: 27F–32F, 1990

Oster G, Epstein AM. Cost-effectiveness of antihyperlipemic therapy in the prevention of coronary heart disease. The case of cholestyramine. Journal of the American Medical Association 258: 2381–2387, 1987

Reves RR, Johnson PC, Ericsson CD, Dupont HL. A cost-effectiveness comparison of the use of antimicrobial agents for treatment or prophylaxis of travelers’ diarrhea. Archives of Internal Medicine 148: 2421–2427, 1988

Rose G. Strategy of prevention: lessons from cardiovascular disease. British Medical Journal 282: 1847–1851, 1981

Schulman KA, Kinosian B, Jacobson TA, Glick H, Willian MK, et al. Reducing high blood cholesterol level with drugs: cost-effectiveness of pharmacologic management. Journal of the American Medical Association 264: 3025–3033, 1990

Torrance GW. Measurement of health state utilities for economic appraisal: a review. Journal of Health Economics 5: 1–30, 1986

Weeks JC, Tierney MR, Weinstein MC. Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia. New England Journal of Medicine 325: 81–86, 1991

Weinstein MC, Fineberg HV, Elstein AS, Frazier HS, Neuhauser D, et al. Clinical decision analysis. W.B. Saunders Company, Philadelphia, 1980

Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. New England Journal of Medicine 296: 716–721, 1977

Weinstein MC. Challenges for cost-effectiveness research. Medical Decision Making 6: 194–198, 1986

Weinstein MC, Read JL, Mackay DN, Kresel JJ, Ashley H, et al. Cost-effective choice of antimicrobial therapy for serious infections. Journal of General Internal Medicine 1: 351–363, 1986